Schonfeld Strategic Advisors LLC Alnylam Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 43,975 shares of ALNY stock, worth $13 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

43,975

Previous 235,606 81.34%

Holding current value

$13 Million

Previous $35.2 Million 69.65%

% of portfolio

0.07%

Previous 0.25%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $27.5 Million - $47.3 Million	-191,631 Reduced 81.34%	43,975 $10.7 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $34.2 Million - $46.3 Million	233,653 Added 11963.8%	235,606 $35.2 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $6.08 Million - $7.89 Million	-40,154 Reduced 95.36%	1,953 $373,000
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $6.77 Million - $8.39 Million	39,641 Added 1607.5%	42,107 $7.46 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $2.36 Million - $2.71 Million	-12,770 Reduced 83.81%	2,466 $468,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $2.78 Million - $3.59 Million	15,236 New	15,236 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $4.66 Million - $7.8 Million	33,615 New	33,615 $6.73 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $806,814 - $1.13 Million	-6,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $852,106 - $1.17 Million	6,700 New	6,700 $1.09 Million
Q3 2021 Nov 16, 2021	SELL	$169.75 - $207.73 $3.22 Million - $3.94 Million	-18,968 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$128.63 - $176.89 $385,890 - $530,670	-3,000 Reduced 13.66%	18,968 $3.22 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $1.78 Million - $2.45 Million	13,868 Added 171.21%	21,968 $3.73 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $1.03 Million - $1.42 Million	8,100 New	8,100 $1.14 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $5.22 Million - $6.46 Million	-73,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $717,874 - $1.01 Million	10,900 Added 17.38%	73,600 $5.34 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $3.47 Million - $4.46 Million	47,700 Added 318.0%	62,700 $5.86 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $3.23 Million - $4.55 Million	-51,500 Reduced 77.44%	15,000 $1.09 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $4.55 Million - $5.55 Million	51,500 Added 343.33%	66,500 $6.55 Million
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $414,414 - $531,030	-3,575 Reduced 19.25%	15,000 $1.79 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $2.13 Million - $2.6 Million	18,575	18,575 $2.36 Million

Others Institutions Holding ALNY

# of Institutions

623

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.15M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $36.5B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Alnylam Pharmaceuticals, Inc. Transaction History